Biotechnology Company Announces Positive Biomarker Data From Major Clinical Trial
NeuroSense Therapeutics Announces Positive Biomarker Data from ALS Phase 2b Clinical Trial.
Disclaimer: The following article is for informational purposes only and should not be construed as medical advice. Always consult a healthcare professional for medical advice, diagnosis, or treatment. The information provided herein is based on the latest available data and research as of the publication date.
Real-time informati…